Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Numinus Wellness Inc. Provides Corporate Update

$NUMIFPress releaseSep 1, 2026, 5:38 AM ETRead the release

Numinus filed all outstanding interim financial reports for fiscal 2026, positioning the company to revoke its BCSC cease trade order and pursue a listing on the Canadian Securities Exchange. Q3 revenue was approximately $1.6 million, flat quarter-over-quarter, with a gross margin of 54.4%. The net loss widened to $314,434 compared to the prior quarter's loss of $161,636.

Key figures

Revenue
1607738
Net loss
314434
Revenue qoq
-0.5%
Gross margin
54.4%
Gross profit
874321
Working capital deficiency
3800000

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.